Concord Biotech Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 14
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedNov 15, 2024
DataAggregated Company Financials
Companies164
- 7D-3.6%
- 3M-0.5%
- 1Y43.9%
- YTD32.0%
In the last week, the Pharma industry is down 3.6% with Cipla down the most at 4.8%. On the other hand Neuland Laboratories is actually up 13%. In the past year, the industry has gained 44%. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 15 Nov 2024 | ₹20.2t | ₹3.8t | ₹519.4b | 33.9x | 38.9x | 5.3x |
| Sun, 13 Oct 2024 | ₹21.7t | ₹3.7t | ₹492.6b | 42.6x | 44x | 5.8x |
| Tue, 10 Sep 2024 | ₹21.3t | ₹3.7t | ₹492.4b | 43x | 43.2x | 5.7x |
| Thu, 08 Aug 2024 | ₹20.2t | ₹3.7t | ₹475.2b | 36.7x | 42.5x | 5.4x |
| Sat, 06 Jul 2024 | ₹18.2t | ₹3.6t | ₹448.3b | 34.6x | 40.6x | 5.1x |
| Mon, 03 Jun 2024 | ₹16.8t | ₹3.6t | ₹452.1b | 32.1x | 37.1x | 4.7x |
| Wed, 01 May 2024 | ₹17.0t | ₹3.5t | ₹418.3b | 34.9x | 40.6x | 4.9x |
| Fri, 29 Mar 2024 | ₹17.0t | ₹3.5t | ₹418.9b | 32.1x | 40.6x | 4.9x |
| Sun, 25 Feb 2024 | ₹17.1t | ₹3.5t | ₹418.6b | 34.8x | 40.8x | 4.9x |
| Tue, 23 Jan 2024 | ₹15.7t | ₹3.4t | ₹395.3b | 34.9x | 39.6x | 4.6x |
| Thu, 21 Dec 2023 | ₹14.2t | ₹3.4t | ₹395.2b | 31x | 36x | 4.2x |
| Sat, 18 Nov 2023 | ₹13.9t | ₹3.4t | ₹395.0b | 31.1x | 35.3x | 4.1x |
| Mon, 16 Oct 2023 | ₹13.2t | ₹3.3t | ₹369.9b | 30x | 35.6x | 4x |
| Wed, 13 Sep 2023 | ₹13.1t | ₹3.3t | ₹369.5b | 29.6x | 35.5x | 4x |
| Fri, 11 Aug 2023 | ₹13.2t | ₹3.2t | ₹359.1b | 29.8x | 36.9x | 4.1x |
| Sun, 09 Jul 2023 | ₹11.7t | ₹3.2t | ₹342.4b | 26.2x | 34.3x | 3.7x |
| Tue, 06 Jun 2023 | ₹10.9t | ₹3.2t | ₹342.5b | 26x | 31.9x | 3.4x |
| Thu, 04 May 2023 | ₹10.0t | ₹3.0t | ₹277.3b | 26.1x | 35.9x | 3.3x |
| Sat, 01 Apr 2023 | ₹9.5t | ₹3.0t | ₹277.5b | 23x | 34.4x | 3.2x |
| Mon, 27 Feb 2023 | ₹9.5t | ₹3.0t | ₹277.5b | 24x | 34.3x | 3.2x |
| Wed, 25 Jan 2023 | ₹9.9t | ₹2.9t | ₹275.0b | 25.6x | 35.9x | 3.4x |
| Fri, 23 Dec 2022 | ₹10.0t | ₹2.9t | ₹274.9b | 26.1x | 36.5x | 3.5x |
| Sun, 20 Nov 2022 | ₹10.1t | ₹2.9t | ₹275.1b | 26.1x | 36.6x | 3.5x |
| Tue, 18 Oct 2022 | ₹9.9t | ₹2.8t | ₹260.4b | 23.8x | 38x | 3.6x |
| Thu, 15 Sep 2022 | ₹9.8t | ₹2.8t | ₹261.9b | 24.1x | 37.3x | 3.5x |
| Sat, 13 Aug 2022 | ₹9.8t | ₹2.8t | ₹266.1b | 22.3x | 36.8x | 3.5x |
| Mon, 11 Jul 2022 | ₹9.5t | ₹2.8t | ₹274.6b | 21.5x | 34.5x | 3.4x |
| Wed, 08 Jun 2022 | ₹9.3t | ₹2.8t | ₹273.7b | 21.3x | 34.1x | 3.4x |
| Fri, 06 May 2022 | ₹9.6t | ₹2.7t | ₹335.7b | 24.1x | 28.7x | 3.6x |
| Sun, 03 Apr 2022 | ₹10.1t | ₹2.7t | ₹337.9b | 23.5x | 29.8x | 3.7x |
| Tue, 01 Mar 2022 | ₹9.6t | ₹2.7t | ₹337.9b | 22.5x | 28.3x | 3.6x |
| Thu, 27 Jan 2022 | ₹10.0t | ₹2.7t | ₹362.2b | 25.2x | 27.7x | 3.8x |
| Sat, 25 Dec 2021 | ₹10.2t | ₹2.7t | ₹360.6b | 24.3x | 28.4x | 3.9x |
| Mon, 22 Nov 2021 | ₹10.1t | ₹2.7t | ₹360.1b | 21.9x | 28.1x | 3.8x |
Price to Earnings Ratio
28.1x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 35.9x.
- The 3-year average PS ratio of 4.1x is lower than the industry's current PS ratio of 5.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 13% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -4.32% | |
| Healthcare | -3.61% | |
| Pharma | -3.57% | |
| Pharma | -3.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 524558 Neuland Laboratories | ₹15.55k | 12.7% +₹22.5b | 194.1% | PE71.3x | |
| CONCORDBIO Concord Biotech | ₹1.90k | 3.8% +₹7.3b | 45.3% | PE60.5x | |
| ERIS Eris Lifesciences | ₹1.35k | 3.9% +₹6.9b | 49.1% | PE52.8x | |
| WOCKPHARMA Wockhardt | ₹1.17k | -3.0% ₹5.0b | 264.9% | PS6.4x | |
| MARKSANS Marksans Pharma | ₹308.30 | 2.2% +₹3.1b | 119.0% | PE40.3x |
